PT1003554E - Inibidor da bomba de protoes em combinacao terapeutica com substancias antibacterianas - Google Patents

Inibidor da bomba de protoes em combinacao terapeutica com substancias antibacterianas

Info

Publication number
PT1003554E
PT1003554E PT98942585T PT98942585T PT1003554E PT 1003554 E PT1003554 E PT 1003554E PT 98942585 T PT98942585 T PT 98942585T PT 98942585 T PT98942585 T PT 98942585T PT 1003554 E PT1003554 E PT 1003554E
Authority
PT
Portugal
Prior art keywords
pump inhibitor
therapeutic combination
antibacterial substances
antibacterial
substances
Prior art date
Application number
PT98942585T
Other languages
English (en)
Inventor
Klaus Tuch
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of PT1003554E publication Critical patent/PT1003554E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT98942585T 1997-07-25 1998-07-21 Inibidor da bomba de protoes em combinacao terapeutica com substancias antibacterianas PT1003554E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97112795 1997-07-25
PCT/EP1998/004553 WO1999004816A1 (en) 1997-07-25 1998-07-21 Proton pump inhibitor in therapeutic combination with antibacterial substances

Publications (1)

Publication Number Publication Date
PT1003554E true PT1003554E (pt) 2005-03-31

Family

ID=8227119

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98942585T PT1003554E (pt) 1997-07-25 1998-07-21 Inibidor da bomba de protoes em combinacao terapeutica com substancias antibacterianas

Country Status (9)

Country Link
US (1) US6303644B1 (pt)
EP (1) EP1003554B1 (pt)
AT (1) ATE281178T1 (pt)
AU (1) AU9067198A (pt)
DE (1) DE69827392T2 (pt)
ES (1) ES2232015T3 (pt)
PT (1) PT1003554E (pt)
SI (1) SI1003554T1 (pt)
WO (1) WO1999004816A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
RS95304A (en) * 2002-05-07 2006-12-15 Altana Pharma Ag. New combination fortreating airway disorders
AU2003229771A1 (en) * 2002-05-07 2003-11-11 Altana Pharma Ag Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20060194748A1 (en) * 2005-02-28 2006-08-31 National University Corporation Nagoya University Methods for treating disorders induced by H. pylori infections and pharmaceutical compositions for the same
GB2479120A (en) 2010-03-26 2011-10-05 Cambridge Display Tech Ltd Organic electrolumunescent device having conductive layer connecting metal over well defining layer and cathode

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
ES2057338T3 (es) 1989-11-29 1994-10-16 Toa Eiyo Ltd Derivados de cicloheptenopiridina, procedimiento para su preparacion y agentes antiulcerosos que los contienen.
GB9018603D0 (en) 1990-08-24 1990-10-10 Smith Kline French Lab Compositions
US5352688A (en) 1991-02-14 1994-10-04 The Mount Sinai School Of Medicine Of The City University Of New York Methods for the treatment of bradyphrenia in parkinson's disease
WO1993012817A1 (en) 1991-12-20 1993-07-08 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
TW276996B (pt) * 1992-04-24 1996-06-01 Astra Ab
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
JPH09188624A (ja) * 1996-01-06 1997-07-22 Takeshi Azuma 肝性脳症治療剤又は肝性脳症予防剤
US6134344A (en) * 1997-06-26 2000-10-17 Lucent Technologies Inc. Method and apparatus for improving the efficiency of support vector machines

Also Published As

Publication number Publication date
DE69827392D1 (de) 2004-12-09
WO1999004816A1 (en) 1999-02-04
ES2232015T3 (es) 2005-05-16
DE69827392T2 (de) 2005-10-27
ATE281178T1 (de) 2004-11-15
EP1003554B1 (en) 2004-11-03
SI1003554T1 (en) 2005-04-30
AU9067198A (en) 1999-02-16
US6303644B1 (en) 2001-10-16
EP1003554A1 (en) 2000-05-31

Similar Documents

Publication Publication Date Title
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
TW200617013A (en) Diazabicyclic central nervous system active agents
CR6577A (es) Inhibidores triciclicos de poli(adp-ribosa) polimerasas
DK1169060T3 (da) Natriumkanalblokkerpræparater og anvendelse deraf
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
BR0011130A (pt) Inibidores de metaloproteases
CY1107467T1 (el) Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχων
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
PT939627E (pt) Pentafluorobenzenossulfonamidas e analogos
PT1272199E (pt) Terapias de combinacao com actividade de lesao vascular
HUP0402421A2 (hu) Mátrix-metalloproteinázokat gátló készítmény neopláziás betegségek kezelésére
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
PT1003554E (pt) Inibidor da bomba de protoes em combinacao terapeutica com substancias antibacterianas
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
PT1051187E (pt) Tratamento de linfomas foliculares usando inibidores da via da linfotoxina (lt)
PT804465E (pt) Novos inibidores da elastase
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
SE0004101D0 (sv) New use
BRPI0408500A (pt) tratamento do diabetes do tipo 1 com inibidores de pde5
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.